Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr285.70 DKK
Change Today -0.10 / -0.03%
Volume 258.0K
As of 6:28 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas Nagy

Executive Vice President of Supply Operations,Novozymes A/S
AgeTotal Calculated CompensationThis person is connected to 98 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Thomas Nagy has been an Executive Vice President of Supply Operations at Novozymes A/S since April 1, 2013. Mr. Nagy served as an Executive Vice President of Stakeholder Relations and COS of Novozymes A/S until April 01, 2013. Mr. Nagy is responsible for stake holder relations, which covers, among other things, People & Organization, Communication and External Affairs. Mr. Nagy was the President of Novozymes North America Inc. since 2004. He served as an Executive ...

Read Full Background

Corporate Headquarters*

Krogshoejvej 36
Bagsvaerd, -- 2880


Phone: 45 44 46 00 00
Fax: 45 44 46 99 99

Board Members Memberships*

Chairman of Industrial & Environmental Section and Director


There is no Education data available.

Other Affiliations*

Annual Compensation*

Total Annual Compensationkr5,900,000

Stock Options*

Long Term Incentive Plankr4,200,000
All Other Compensationkr1,400,000
Total Number of Options158,698

Total Compensation*

Total Annual Cash Compensationkr7,300,000
Total Short Term Compensationkr5,900,000
Other Long Term Compensationkr1,400,000
Total Calculated Compensationkr11,500,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NZYMB:DC kr285.70 DKK -0.10


Paul Manning Chief Executive Officer, President, Director, Member of Executive Committee, Member of Finance Committee and Member of Scientific Advisory Committee
Sensient Technologies Corporation
Stan McCarthy Chief Executive Officer and Executive Director
Kerry Group plc
Magdalena Martullo-Blocher Vice-Chairman and Chief Executive Officer
EMS-Chemie Holding AG
Antonio Hernández Callejas Chairman, Chief Executive Officer, Chairman of Executive Committee and Member of Strategy & Investment Committee
Ebro Foods SA
Cees de Jong M.D., MBAChief Executive Officer, President and Member of Executive Board
Chr. Hansen Holding A/S
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVOZYMES A/S-B SHARES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at